Abstract
Objective: Management of right ventricular (RV) dysfunction is challenging. Current practice predominantly is based on data from experimental and small uncontrolled studies and includes augmentation of blood pressure. However, whether such intervention is effective in the clinical setting of cardiac surgery is unknown.
Design: Randomized controlled trial.
Setting: Single-center study in a tertiary teaching hospital.
Participants: The study comprised 78 patients equipped with a pulmonary artery catheter (PAC), classified according to PAC-derived RV ejection fraction (RVEF); 44 patients had an RVEF of = 20% and
Interventions: Patients randomly were assigned to either a normal target group (mean arterial pressure 65 mmHg) or a high target group [mean arterial pressure 85 mmHg]). The primary end- point was the change in RVEF over a one-hour study period.
Measurements and Main Results: There was no significant between-group difference in change of RVEF
Conclusion: In a mixed cardiac surgery population with RV dysfunction, norepinephrine-mediated high blood pressure targets did not result in an increase in PAC-derived RVEF compared with normal blood pressure targets. (C) 2021 The Authors. Published by Elsevier Inc.
Original language | English |
---|---|
Pages (from-to) | 2980-2990 |
Number of pages | 11 |
Journal | Journal of cardiothoracic and vascular anesthesia |
Volume | 35 |
Issue number | 10 |
Early online date | 2021 |
DOIs | |
Publication status | Published - Oct-2021 |
Keywords
- bloodpressure targets
- right ventricular dysfunction
- pulmonary artery catheter
- transesophageal echocardiography
- cardiac surgery
- HEART-FAILURE
- SEPTIC SHOCK
- VOLUME OVERLOAD
- NOREPINEPHRINE
- MANAGEMENT
- PATHOPHYSIOLOGY
- VASOPRESSORS
- STATEMENT
- OUTPUT
- ARTERY